TODAY'S HEADLINES

FDA approves first monthly PCSK9 inhibitor injection

FDA approved evolocumab (Repatha) Pushtronex system, the first monthly single-dose injection of a PCSK9 inhibitor. Read more

Zika vaccine on the horizon

The US government and Emergent Biosolutions plan to bring a vaccine for the Zika virus to market immediately to the tune of $21.9 million. Read more

CONTINUING PHARMACY EDUCATION

Expanding vaccination rates through pharmacist-initiated patient identification and assessment

This month's CE activity, "Expanding vaccination rates through pharmacist-initiated patient identification and assessment," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians about current vaccine recommendations so that they can identify adolescent and adult patients who may need vaccinations. Readers will also gain knowledge about where to obtain information about current vaccine recommendations.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More

EDITOR'S PICK

FDA approves cannabis-derived drug

FDA approved the first cannabis-derived liquid solution, dronabinol oral solution (Syndros), from the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol (THC). Find out how the liquid solution provides new treatment options. Read more

July 20, 2016

Related Articles

Battle of the cholesterol drugs expected

Top 5 things to know about FDA's Zika blood guidelines